MétaCan
Menu
Back to cohort
Record W7108219887 · doi:10.69750/dmls.02.010.0168

Glycemic Outcomes of Oral Hypoglycemics Versus GLP-1 Receptor Agonists in Type 2 Diabetes: A Comparative Clinical Study

2025· article· W7108219887 on OpenAlexaff

Bibliographic record

VenueDevelopmental medico-life-sciences · 2025
Typearticle
Language
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsCollège Montmorency
Fundersnot available
KeywordsGlycemicType 2 Diabetes MellitusBlood sugarDiabetes mellitusHypoglycemiaClinical studyAgonistAdverse effect

Abstract

fetched live from OpenAlex

Background: Type 2 Diabetes Mellitus (T2DM) is one of the most significant health concerns around the world, especially in South Asian communities, where the escalating burden of obesity and sedentary lifestyles has intensified the disease. Although oral hypoglycemic agents (OHAs) remain first-line treatment, glucagon-like peptide-1 (GLP-1) receptor agonists have become an effective alternative since they have a glucose-dependent insulinotropic effect, reduce weight, and have fewer adverse effects, particularly hypoglycemia. There is limited comparison of clinical evidence of local settings, however. Objectives: To evaluate the efficacy of OHAs and GLP-1 receptor agonists in enhancing glycemic regulation in adults with T2DM. Methods: A comparative clinical study was carried out in Shaikh Zayed Hospital, Lahore, between January 2024 and March 2025. Eighty adult participants with T2DM were recruited through consecutive sampling and separated into 2 equal groups: Group A was provided with regular OHAs and Group B was prescribed GLP-1 receptor agonists. Fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c were measured at baseline and 6 months. Statistical software SPSS 26 version was utilized and p less than 0.05 was regarded to be significant. Findings: Both groups experienced an improvement in glycemic parameters and the GLP-1 group had significantly more decreases in the HbA1c (1.8 vs. 1.0), FBS and RBS (p < 0.01). Also, the GLP-1 group obtained significant losses (3.4 kg) in weight, but the OHA did not. Hypoglycemia was more prevalent among users of OHA whereas gastrointestinal symptoms were a little bit more prevalent among users of GLP-1. Conclusion: GLP-1 receptor agonists offer a benefit in glycemic control and weight loss over traditional OHAs and reduced hypoglycemic events. These agents are a good therapeutic alternative in the management of T2DM, particularly when the patient needs a better metabolism.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.016

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.119
GPT teacher head0.406
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueDevelopmental medico-life-sciencesSame topicDiabetes Treatment and ManagementFrench-language works237,207